文献速递神经肿瘤

2HG MRS与IVIM联合及单独参数在临床场景中预测胶质瘤IDH突变状态的诊断效能:一项回顾性研究

The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.
PubMed 文献 · J Neurooncol · 2024-02-29

该回顾性研究纳入64例胶质瘤患者,比较IDH野生型与突变型间2HG浓度及IVIM衍生参数的差异,并用ROC曲线和DeLong检验评估各参数及联合方案的诊断效能。结果显示IDH突变型2HG浓度、rADC和rD更高,rD*更低;2HG+rD+rD*的AUC最高(0.967,95%CI 0.889-0.996),联合方案较单独参数诊断效能显著提升(DeLong检验P<0.05)。

要点

  • IDH突变型胶质瘤较野生型2HG浓度、rADC和rD更高(P<0.001),rD*更低(P=0.013)。
  • 2HG+rD+rD*鉴别IDH突变状态的AUC最高,为0.967(95%CI 0.889-0.996)。
  • 2HG+rADC+rD*与2HG+rD+rD*较各单独参数诊断效能显著提升(DeLong检验P<0.05)。

核心结论

  • 2HG MRS与IVIM联合可显著提高临床场景中预测胶质瘤IDH突变状态的诊断效能。

研究设计与样本

  • 回顾性研究,纳入符合纳入标准的患者并分为IDH野生型组和IDH突变型组,共64例(女性21例,男性43例,年龄47.0±13.7岁)。
  • 定量2HG浓度、相对表观扩散系数(rADC)、相对真实扩散系数(rD)、相对伪扩散系数(rD*)和相对灌注分数(rf)。
  • 采用t检验和Mann-Whitney U检验比较组间差异,用ROC曲线和DeLong检验评估并比较单独参数及其联合方案的诊断效能。

主要发现

  • 与IDH野生型胶质瘤相比,IDH突变型胶质瘤2HG浓度、rADC和rD更高(P<0.001),rD*更低(P=0.013)。
  • 2HG+rD+rD*鉴别IDH突变状态的AUC最高,为0.967(95%CI 0.889-0.996)。
  • 与各单独参数相比,2HG+rADC+rD*和2HG+rD+rD*的预测效能有统计学显著提升(DeLong检验P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Currently, there remains a scarcity of established preoperative tests to accurately predict the isocitrate dehydrogenase (IDH) mutation status in clinical scenarios, with limited research has explored the potential synergistic diagnostic performance among metabolite, perfusion, and diffusion parameters. To address this issue, we aimed to develop an imaging protocol that integrated 2-hydroxyglutarate (2HG) magnetic resonance spectroscopy (MRS) and intravoxel incoherent motion (IVIM) by comprehensively assessing metabolic, cellular, and angiogenic changes caused by IDH mutations, and explored the diagnostic efficiency of this imaging protocol for predicting IDH mutation status in clinical scenarios. METHODS: Patients who met the inclusion criteria were categorized into two groups: IDH-wild type (IDH-WT) group and IDH-mutant (IDH-MT) group. Subsequently, we quantified the 2HG concentration, the relative apparent diffusion coefficient (rADC), the relative true diffusion coefficient value (rD), the relative pseudo-diffusion coefficient (rD*) and the relative perfusion fraction value (rf). Intergroup differences were estimated using t-test and Mann-Whitney U test. Finally, we performed receiver operating characteristic (ROC) curve and DeLong's test to evaluate and compare the diagnostic performance of individual parameters and their combinations. RESULTS: 64 patients (female, 21; male, 43; age, 47.0 ± 13.7 years) were enrolled. Compared with IDH-WT gliomas, IDH-MT gliomas had higher 2HG concentration, rADC and rD (P < 0.001), and lower rD* (P = 0.013). The ROC curve demonstrated that 2HG + rD + rD* exhibited the highest areas under curve (AUC) value (0.967, 95%CI 0.889-0.996) for discriminating IDH mutation status. Compared with each individual parameter, the predictive efficiency of 2HG + rADC + rD* and 2HG + rD + rD* shows a statistically significant enhancement (DeLong's test: P < 0.05). CONCLUSIONS: The integration of 2HG MRS and IVIM significantly improves the diagnostic efficiency for predicting IDH mutation status in clinical scenarios.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Yu M, Ge Y, Wang Z, et al. The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study. J Neurooncol. 2024. PMID: 38424338. doi:10.1007/s11060-024-04609-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。